glp 1 in europe Health authorities have given the green light for the first GLP-1 gene therapy trial to take place. Read more: https://thehill.com/policy/healthcare/5880938-first-human-glp-1 -gene-therapy-trial European regulators want to know

Ozempic is about to be old news, my colleague Yasmin Tayag wrote in 2023, just before an even more powerful obesity drug, tirzepatide, then best known as Mounjaro, was approved

Indeed, dulaglutide shows sex-specific treatment differences, as males reduce their intake levels more than females, and the treatment effect persists after discontinuation in males but not in females (Vallof et al., 2020)

Drug shortages : A compounded version may be created when an FDA-approved drug is unavailable due to short supply issues

This parallel marketplace has led to off-label drug usage, misleading marketing, counterfeit brand name drugs with high levels of bacteria or other impurities, and general concern for patient safety

Some cases happen when a pet is mistakenly given the medication that was prescribed for a human in the household